Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

METTLER TOLEDO INTERNATIONAL INC/ (MTD)

As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data

Report price $1,727.26 (close 2026-11-16); latest close $1,666.88 (2026-11-20), -3.5% since the report; figures re-marked at the latest close

Conclusion: PASS

Conviction medium · base case -6% · downside -28% · upside +17%

The business is high quality — 45.8% ROIC against an 8.2% WACC, a 20.7% FCF margin — but at $1,727.26 the market already pays for it: 36.8x TTM earnings, 28.4x EV/EBITDA, and a reverse DCF that needs +12.5% revenue growth a year for ten years against +4.0% in the latest fiscal year. Nothing in the news flow explains the price; the multiple does. That is why the call is PASS — the quality is real, but the entry price leaves no margin of safety. The cases bracket the outcome: the downside is $1,199.69, -30.5%, on -10.0% earnings at a compressed P/E of 28.4x (today 36.8x); the base is $1,572.37, -9.0%, on a P/E at 33.5x, the peer median P/E; the upside is $1,951.80, +13.0%, on +13% earnings at today's P/E of 36.8x. The distribution is skewed against the buyer: the largest move on the board is the downside, and the upside is the smallest.

Key numbers

  • Share price: $1,666.88
  • Market cap: $33.15B
  • Latest financial period: TTM to Sep 30, 2026
  • Revenue (TTM): $4.20B
  • EV / EBITDA (TTM): 27.5x
  • P/E (TTM): 35.5x
  • FCF yield: 2.6%
  • Price / book: 426.92x
  • Earnings-quality flags (TTM): none flagged
  • EV / FCF (TTM): 40.3x
  • Revenue growth (latest fiscal year): +4.0%
  • ROIC (TTM): 45.8%
  • WACC: 8.2%
  • Economic profit spread: +37.6 pts

The 15 boxes

  1. ✓ 1. Long-form business notes

    MTD is a global precision-instrument maker selling lab instruments (~56% of FY2025 net sales), industrial instruments (~39%) and retail weighing (~5%), through five reportable segments and a ~9,300-person sales and service organization in ~40 countries. Its history shows steady scale-up with a sharp margin of resilience: revenue went $3.09B (FY2020) to $4.03B (FY2025) and $4.20B on a TTM basis to Sep 2026, while net income went $602.7M to $869.2M to $934.1M over the same spans, with only FY2023 showing a dip. The mix has drifted toward the Americas (42% of FY2025 net sales vs 38% in FY2020) and toward lab instruments and service (service 25% of FY2025 net sales vs 23% in FY2023). Capital return, not operations, drives the balance sheet: buybacks of $775.0M to $1.10B a year took total equity from $282.7M (FY2020) to -$23.6M (FY2025), only partly recovered to $77.7M at the TTM date.

  2. ✓ 2. Competitive advantage

    The filings claim a real competitive moat — worldwide market leadership, global brand, innovation track record, a large installed base, and diversification — and the numbers are consistent with it: gross profit grew from $1.80B (FY2020) to $2.39B (FY2025) and $2.54B (TTM to 2026-09-30) as revenue went from $3.09B to $4.03B to $4.20B, with no visible gross-margin erosion, while operating cash flow ($955.8M FY2025, $984.4M TTM) exceeds net income ($869.2M, $934.1M) on capex of only $107.1M and $113.8M. But the 10-K itself calls the markets "highly competitive" and fragmented, with regional, larger-parent and lower-cost emerging-market rivals, and states these forces "can impair our operating margins." The moat is thus pricing power and installed-base/service lock-in rather than an uncontested market; China (16% of 2025 external sales, 29% of segment profit, ~29% of production) and tariff costs (~$50M in 2025) are the main pressure points on it.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 sales rose 6% reported and in local currency to $1.094B, with Asia/Rest of World local currency +14%; gross margin was 59.8% and adjusted operating profit $333.5M. GAAP diluted EPS was $12.29 and adjusted EPS $12.57; nine-month figures include a one-time net tariff-refund benefit that should be kept out of operating trends. Management guides Q4 2026 local currency sales +~5% and adjusted EPS $14.84-$15.04, and FY2026 adjusted EPS $47.70-$47.90. The 10-Q reports no material risk-factor changes.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ✓ 9. Insider trading interpretation

    Filled; members read this box.

  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans